A new way to detect cognitive impairment in older adults using a tablet.
A Pragmatic Trial of the UCSF Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
This study is testing a new, easy-to-use tablet tool that helps doctors in primary care spots better spot cognitive issues like dementia, so if you join in, you could get a clearer and quicker diagnosis for any memory or thinking problems you might have.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10923987 on NIH RePORTER |
What this research studies
This research focuses on improving the detection of cognitive impairment, including dementia, in primary care settings. It utilizes the UCSF Brain Health Assessment, which is a user-friendly tablet interface that automates scoring and integrates with electronic medical records. The study aims to evaluate the effectiveness of this assessment in various primary care clinics, while also addressing implementation challenges and refining detection algorithms to ensure they are suitable for a diverse population. By participating, patients may benefit from more accurate and timely diagnoses of cognitive issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who may be experiencing cognitive difficulties.
Not a fit: Patients under the age of 65 or those without any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of cognitive impairment in older adults, improving patient outcomes.
How similar studies have performed: Previous research has shown success in using technology for cognitive assessments, making this approach promising yet innovative in its specific application.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Possin, Katherine Laurel — University of California, San Francisco
- Study coordinator: Possin, Katherine Laurel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.